ArterX Safety and Efficacy Study for Cardiac Indications

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

September 30, 2013

Study Completion Date

December 31, 2013

Conditions
Vascular Disease
Interventions
DEVICE

ArterX Surgical Sealant

Trial Locations (1)

Unknown

Krankenhaus Der Barmherzigen Bruder, Trier

All Listed Sponsors
lead

Tenaxis Medical, Inc.

INDUSTRY

NCT01957904 - ArterX Safety and Efficacy Study for Cardiac Indications | Biotech Hunter | Biotech Hunter